Be a part of 5^th International Conference on Diabetes and Endocrinology

Session 1:  Diabetes & Diabetic Complications
Providing a comprehensive understanding of diabetes mellitus, covering its epidemiology, etiology, pathophysiology, and diagnostic criteria to lay the foundation for subsequent discussions on management and complications.
Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Diabetes Mellitus
Exploring the multifaceted complications arising from diabetes, including microvascular and macro vascular complications, alongside strategies for prevention, early detection, and optimal management with Foot Complications, Gastroparesis, Hypoglycemia
Diabetes Conference | Diabetes Mellitus Events | Dialysis Congress | Gestational Diabetes Meetings | Prediabetes Workshops

Session 2: Diabetes Diagnosis and Treatment - Insulin Therapy
Health Care professionals can diagnose diabetes, prediabetes, and gestational diabetes through blood tests. The blood tests show if your blood glucose, is too high or low. Type 1 diabetes seen in children and young adults. Because type 1 diabetes can run in families, even if they don’t have symptoms. Experts suggests testing children between the ages of 10 and 18 who are overweight or obese and have at least two other risk factors for developing diabetes.
Delving into the principles, modalities, and advancements in insulin replacement therapy for diabetes management, encompassing insulin types, administration techniques, dose titration, and strategies to optimize glycemic control while minimizing hypoglycemia and other adverse effects
Diabetes Diagnosis & Treatment Meetings| Insulin Therapy Workshops  | Hypoglycemia Congress | Autoimmune Disease Conference | Blood Glucose Meetings | Cardiovascular Disease Conference | Diabetic Ketoacidosis Workshops

Session 3: Obesity and Metabolic Syndrome
Obesity occurs when a man's muscle mass exceeds his fat mass to the point where it threatens his health. A man is considered corpulent if his body weight is at least 20% more than it should be. If your Body Mass Index (BMI) is between 25 and 29.9, you are considered overweight. If your BMI is 30 or over, you are considered overweight. Diabetes mellitus is a chronic, long-term disease that affects your body's ability to utilise the energy available in food. Type 1 diabetes, type 2 diabetes, and gestational diabetes are the three types of diabetes to be aware of. Something similar can be found in a wide variety of diabetes mellitus. Normally, your body converts the sugars and carbs you consume into a single sugar known as glucose.
Endocrine Health Summit | Diabetes Innovation Forum| Hormone Disorders Symposium | Metabolic Disorders Conference | Thyroid and Diabetes Congress | Endocrine Disorders Update | Pancreatic Disorders Conference | Insulin Resistance Symposium | Pediatric Endocrinology Summit | Diabetes Care Symposium

Session 4: Diabetes Wound Care and Management
Diabetic patients' wound healing slows down due to a variety of causes, including diabetes. High glucose levels (When your glucose level is greater than normal, it prevents nutrients and oxygen from reaching cells, preventing your immune system from functioning properly and, in the long run, causing aggravation in the body's cells.) (Neuropathy) is the damage caused to nerve cells as a result of persistently elevated glucose levels. This could result in a loss of sensation in the affected areas. Diabetic individuals' hands and feet are commonly affected. When it occurs, one will be unable to feel wounds when they happen. This is one noteworthy motivation behind why foot wounds have a tendency to be more typical in individuals with diabetes.
Hypoglycemia Congress | Autoimmune Disease Conference | Blood Glucose Workshops | Cardiovascular Disease Meetings | Diabetic Ketoacidosis Meetings

Session 5:  Pre-Diabetes and Cardiovascular Diseases
A diagnosis of prediabetes should serve as a wake-up call to patients to undertake lifestyle adjustments that will help them avoid full-blown diabetes and cardiovascular disease (CVD). We know that having diabetes raises the risk of acquiring cardiovascular disease, therefore we wanted to see what the absolute risk or probability of developing heart disease was for those with blood sugar levels that were only slightly higher than pre-diabetic. A fasting blood sugar level of 100 to 125 mg/dL (5.6 to 6.9 mmol/L) indicates prediabetes, but a fasting blood sugar level of less than 100 mg/dL (5.6 mmol/L) is considered normal. The diagnostic threshold for diabetes is 126 mg/dL (7 mmol/L) or higher.
Pre-Diabetes Meetings | Cardiovascular Diseases Congress | Diabetes Events | Diabetes Mellitus Congress | Dialysis Meetings | Gestational Diabetes Workshops | Prediabetes Conference

Session 6: Endocrine Glands & Endocrine Oncology
Delving into the latest advancements in basic and translational research focused on elucidating the physiology, pathophysiology, and therapeutic targets of endocrine glands, spanning from molecular mechanisms to clinical applications.
Types of Glands:

• Molecular Biology
• Signal Transduction
• Therapeutics

Scrutinizing the diagnosis, staging, treatment modalities, and multidisciplinary management of endocrine-related malignancies, encompassing thyroid, adrenal, pituitary, and neuroendocrine tumors, and addressing emerging therapeutic approaches and challenges.Thyroid Cancer, Adrenal Tumors, Pituitary Tumors, Parathyroid Cancer, Neuroendocrine Tumors, Endocrine Pancreatic Tumors, Surgical Interventions
Endocrine Galnds conference | Endocrine Ongology Meetings | Diabetes Diagnosis & Treatment Workshops| Insulin Therapy Congress  | Hypoglycemia Conference | Autoimmune Disease Meetings | Blood Glucose Conference | Cardiovascular Disease Workshops | Diabetic Ketoacidosis Meetings

Session 7: Endocrinology and Metabolic Disorder
Endocrine diseases influence the body's ability to digest certain nutrients and vitamins, whereas metabolic disorders affect the body's ability to over- or under-produce certain hormones. Hypothyroidism, congenital adrenal hyperplasia, parathyroid gland diseases, diabetes mellitus, adrenal gland diseases (including Cushing's syndrome and Addison's disease), and ovarian dysfunction (including polycystic ovary syndrome) are among the endocrine disorders. The study of hormone processes and neuroendocrine systems that influence or govern behaviour is known as behavioural endocrinology. Endocrinology is a broad field that impacts not just our endocrine system but also our skin, implying that dermatology is involved indirectly.
Endocrine Health Summit | Diabetes Innovation Forum| Hormone Disorders Symposium | Metabolic Disorders Conference | Thyroid and Diabetes Congress | Endocrine Disorders Update | Pancreatic Disorders Conference | Insulin Resistance Symposium | Pediatric Endocrinology Summit | Diabetes Care Symposium

Session 8: Infertility & Reproduction Health Care
In the differential diagnosis of menstrual irregularities and infertility, diabetes mellitus Type 1 and Type 2 should be examined. Diabetic women's reproductive periods may be shortened as a result of delayed menarche and premature menopause. Diabetes has been linked to menstruation disorders such as oligomenorrhea and secondary amenorrhea during the reproductive years. Better glycemic control and the prevention of diabetic complications were discovered to improve these abnormalities and bring fertility rates closer to those reported in the general population. Women with persistent menstrual abnormalities despite adequate treatment need to be approached by broader evaluation, which will include the examination of the hypothalamic-pituitary-ovarian axis and the hormonal status, presence of autoimmune thyroid disease and antiovarian autoantibodies, and hyperandrogenism.
Hypoglycemia Congress | Autoimmune Disease Conference | Blood Glucose Workshops | Cardiovascular Disease Meetings | Diabetic Ketoacidosis Meetings

Session 9: Thyroid Imbalance Insights
Providing insights into the spectrum of thyroid disorders, including hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer, exploring diagnostic modalities, treatment options, and considerations for personalized management.

• Autoimmune Thyroid Disorders
• Treatment Options
• Thyroid Function Tests

Thyroid Congress | Diabetes Congress | Diabetes Mellitus Meetings | Dialysis Workshops | Gestational Diabetes Conference | Prediabetes Events

Session 10: Mental Health in Endocrine Care
Examining the bidirectional relationship between mental health disorders and endocrine conditions, addressing the impact of hormonal imbalances on mood, cognition, and behavior, and integrating mental health considerations into comprehensive endocrine care.

• Psychological Impact
• Emotional Well-being
• Psychiatric Comorbidities

Metal Health Meetings| Insulin Therapy Workshops  | Hypoglycemia Congress | Autoimmune Disease Conference | Blood Glucose Meetings | Cardiovascular Disease Conference | Diabetic Ketoacidosis Workshops

Session 11: Pediatric & Neuroendocrinolog
Addressing the unique aspects of diagnosing, treating, and managing endocrine disorders in pediatric populations, encompassing growth disorders, puberty-related issues, congenital adrenal hyperplasia, diabetes, and other hormone-related conditions like Growth Disorders, Diabetes in Children, Genetic Syndromes. Exploring the intricate interplay between the endocrine system and the central nervous system, elucidating neuroendocrine pathways, and their roles in regulating homeostasis, stress responses, mood, behavior, and reproductive function.

• Neuroendocrine Disorders
• Stress Response
• Neurotransmitters
• Hypothalamus-Pituitary Axis

Endocrine Health Summit | Diabetes Innovation Forum| Hormone Disorders Symposium | Metabolic Disorders Conference | Thyroid and Diabetes Congress | Endocrine Disorders Update | Pancreatic Disorders Conference | Insulin Resistance Symposium | Pediatric Endocrinology Summit | Diabetes Care Symposium

Session 12: Osteoporosis Health Care
Osteoporosis is a global age-related health concern that affects both male and female senior people. It slowly deteriorates the microstructure of bone, especially at trabecular locations like vertebrae, ribs, and hips, leading to fragility fractures, pain, and disability. Diabetes mellitus (DM), particularly type 1 DM, leads to and/or aggravates bone loss in osteoporotic patients, despite the fact that osteoporosis is generally associated with ageing and oestrogen shortage. This subject spotlight article covers DM-induced osteoporosis and DM/osteoporosis comorbidity, as well as changes in bone metabolism and hormones that regulate bone formation in diabetic patients, such as insulin, insulin-like growth factor-1, and angiogenesis. Also covered are the cellular and molecular processes of DM-related bone loss. This knowledge lays the groundwork for a better understanding of diabetes complications as well as the development of early osteoporosis screening and prevention in diabetic patients.
Hypoglycemia Conference | Autoimmune Disease Conference | Blood Glucose Conference | Cardiovascular Disease Conference | Diabetic Ketoacidosis Conference

Session 13: Diet and Physical Activity
Investigating the impact of dietary factors and interventions on endocrine health, including nutritional approaches to diabetes management, weight loss, metabolic syndrome, and other hormone-related conditions, and exploring dietary guidelines and lifestyle modifications.

• Diabetes Management
• Weight Management
• Calcium and Vitamin D Supplementation
• Medical Nutrition Therapy
• Behavioral Counseling

Diet and Physical Activity Events | Diabetes Mellitus Workshops | Dialysis Conference | Gestational Diabetes Events | Prediabetes Workshops

Diabetes can affect almost every part of your body and cause other complications . Therefore, managing the blood glucose levels, also called blood sugar is very necessary. Managing the  blood glucose, as well as blood pressure and cholesterol, can help prevent the secondary health problems that can occur when you have diabetes.

FUNDING:
The diabetes market worldwide has been driven by increasing obesity rates, lack of proper exercise and accelerating stress levels in every country. Support from different  government system across the world which extend plans and initiatives to help control the damage done by the rising diabetes cases and trying to combat  the situation in different possible ways.
The digital diabetes management market is projected to reach USD 19.98 billion by 2024, from an estimated USD 6.87 billion in 2019, at a CAGR of 23.8. The rising occurrence of diabetes has increased the emphasis on the development and adoption of better solutions for diabetes care. Also hand in hand is the advancements in technologies which  has ensured the introduction of highly flexible solutions in the market .These are the major factors driving the growth of the global digital diabetes management market. The increasing adoption of cloud-based enterprise solutions and the growing use of connected devices and apps are some of the other major factors supporting market growth.
Diabetes in Europe
There are about 60 million people with diabetes in the European Region, or about 10.3% of men and 9.6% of women aged 25 years and over. Prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity.   The European diabetes devices market is expected to record a high CAGR of 7.51% during the forecast period (2019 - 2024), due to the growing prevalence of diabetes, growing geriatric population levels, unhealthy diet, and increasing levels of physical inactivity.
Diabetes in America
Diabetes was the seventh leading cause of death in the United States in 2015 based on the 79,535 death certificates in which diabetes was listed as the underlying cause of death. In 2015, diabetes was mentioned as a cause of death in a total of 252,806 certificates. Diabetes may be underreported as a cause of death. Studies have found that only about 35% to 40% of people with diabetes who died had diabetes listed anywhere on the death certificate and about 10% to 15% had it listed as the underlying cause of death.
Diabetes in Asia
The last three decades have witnessed an epidemic rise in the number of people with diabetes, especially type2 diabetes, and particularly in developing countries, where more than 80% of the people with diabetes live. The rise of type 2 diabetes in South Asia is estimated to be more than 150% between 2000 and 2035. Although aging, urbanization, and associated lifestyle changes are the major determinants for the rapid increase, an adverse intrauterine environment and the resulting epigenetic changes could also contribute in many developing countries. The International Diabetes Federation estimated that there were 382 million people with diabetes in 2013, a number surpassing its earlier predictions. More than 60% of the people with diabetes live in Asia, with almost one-half in China and India combined. The Western Pacific, the world’s most populous region, has more than 138.2 million people with diabetes, and the number may rise to 201.8 million by 2035.
Diabetes in Middle East and Africa
According to the International Diabetes Federation Atlas, 19.3 percent of adults aged 20 to 79 in the United Arab Emirates are diabetic. In Bahrain, the percentage rises to 19.6—and the statistic jumps to 20 percent for Kuwait, Qatar, and Saudi Arabia. According to the IDF Diabetes Atlas 8th Edition, approximately 38.7 million adults aged 20-79 years were living with diabetes in the Middle East and North Africa Region in 2017. Over two-thirds (67.3%) of adults with diabetes live in urban areas.

In Middle East & Africa (MEA), 15.51 million people are suffering from diabetes, and this population is expected to increase in the forecast period with a CAGR of 4.46%.
The Middle East & Africa diabetes drugs market (henceforth, referred to as the market studied) was valued at USD 2793.99 million in 2018, and it is expected to witness a CAGR of 6.48% during the forecast period 2019 - 2024, primarily due to the growing geriatric population.

Societies Associated with Diabetes Care
•    Endocrine Society Australia, Australia
•    American Diabetes Association, Virginia
•    European Society of Endocrinology, UK
•    British Society for Neuroendocrinology, London
•    International Neuroendocrine Federation, Canada
•    Association of British Clinical Diabetologist, UK
•    International Society of Endocrinology, Switzerland
•    Panhellenic Association of Endocrinologists, Greece
•    Spanish Society of Endocrinology and Nutrition, Spain
•    International Society of Psych neuroendocrinology, Italy
•    The American Association of Clinical Endocrinology, Florida
•    British Society for Paediatric Endocrinology and Diabetes, UK
•    British Association of Endocrine and Thyroid Surgeons, London
•    Royal Society of Medicine Endocrinology and Diabetes Section, London
•    Egyptian Association of Endocrinology, Diabetes and Atherosclerosis, Egypt

Global Universities Associated with Diabetes and Endocrinology
America Region

•    University of Alabama, USA
•    Mayo Medical School, USA
•    University of Arizona, USA
•    University of Arizona, USA
•    University of Arkansas, USA
•    California North state University, USA
•    Charles R. Drew University of Medicine and Science, USA
•    Keck School of Medicine of University of Southern California, USA
•    Loma Linda University, USA
•    Stanford University, USA
•    University of California, USA
•    George Washington University, USA
•    Florida International University, USA
•    University of Florida, USA
•    University of Calgary, Canada
•    University of Western Ontario, Canada
•    University of Waterloo, Canada
•    University of Montreal, Canada
•    McMaster University, Canada
•    University of Alberta, Canada
•    University of Sao Paulo, Brazil
•    Federal University of Rio De Janeiro, Brazil
•    Sao Paulo State University, Brazil
•    Federal University of Sao Paulo, Brazil
•    Federal University of Rio Grande Do Sul, Brazil

Asia Region
•    The University of Tokyo, Japan
•    National University of Singapore, Singapore
•    Kyoto University, Japan
•    University of Hong Kong, Hong Kong
•    Peking University, China
•    Seoul National University, South Korea
•    National Taiwan University, Taiwan
•    Osaka University, Japan
•    Nanyang Technological University, Singapore
•    Sungkyunkwan University, South Korea
•    Universiti Malaya, Malaysia
•    Indian Institute of Science, India
•    Universiti Kebangsaan Malaysia, Malaysia
•    University of Indonesia, Indonesia
•    Indian Institute of Technology Bombay, India
•    The Hong Kong University of Science and Technology (HKUST), Hong Kong

Middle East Region
•    Arabian Gulf University, Bahrain
•    Faculty of Medicine Zagazig University, Egypt
•    Benha University, Egypt
•    Fayoum Faculty of Medicine, Egypt
•    Bushehr University of Medical Sciences, Iran
•    Dezful University of Medical Sciences, Iran
•    Fasa Faculty of Medical Sciences, Iran
•    University of Kerabala, Iraq
•    University of Duhok, Iraq
•    Thi Qar University, Iraq
•    Minia Medical School, Egypt
•    Royal College of Surgeons in Ireland, Bahrain
•    Fatemiye University of Medical Sciences, Iran
•    Assiut Faculty of Medicine, Egypt
•    Suez Canal Faculty of Medicine, Egypt

Europe Region
•    LMU Munich, Germany
•    Technical University of Munich, Germany
•    University of Leuven, Belgium
•    University of Amsterdam, Netherlands
•    Humboldt University of Berlin, Germany
•    Leiden University, Netherlands
•    Utrecht University, Netherlands
•    Erasmus University Rotterdam, Netherlands
•    RWTH Aachen University, Germany
•    University of Groningen, Netherlands
•    University of Copenhagen, Denmark
•    University of Barcelona, Spain
•    University of Helsinki, Finland

Global Diabetes-endocrinology Research Centre’s
•    Joslin Diabetes Centre, USA
•    Diabetes Research Institute Foundation, USA
•    UCSF Diabetes Center, USA
•    Mayo Clinic, USA
•    Vanderbilt Diabetes Center, USA
•    Euradia, England
•    Dyna Health, Finland
•    Oxford Centre for Diabetes, Endocrinology and Metabolism, England
•    Lundberg Laboratory for Diabetes Research, Sweden
•    German Center for Diabetes Research, Sweden
•    Diabetes Complications Research Centre, Ireland
•    Dubai Diabetes Center, UAE
•    Diabetes Research Center, Japan
•    Imperial College London Diabetes Center, UAE
•    Hong Kong Institute of Diabetes and Obesity, China
•    Korea University Medical Center, South Korea
•    Tel Aviv Sourasky Medical Center, Israel
•    Sheba Medical Center, Israel
•    RAK Diabetes Center, UAE

Global Diabetes-Endocrinology Medicals/Hospitals

America Region
•    Cleveland Clinic, USA
•    Massachusetts General Hospital, USA
•    Johns Hopkins Hospital, USA
•    UCSF Medical Center, USA
•    New York-Presbyterian University Hospital of Columbia and Cornell, Canada
•    Yale-New Haven Hospital, USA
•    Northwestern Memorial Hospital, USA
•    UCLA Medical Center, Canada
•    University of Washington Medical Center, USA
•    Hospitals of the University of Pennsylvania-Penn Presbyterian, USA
•    Brigham and Women’s Hospital, USA
•    Florida Hospital Orlando, USA
•    Cedars-Sinai Medical Center, Canada
•    Barnes-Jewish Hospital/Washington University, USA
•    Beaumont Hospital, USA
•    Mount Sinai Hospital, USA
•    Froedtert Hospital and the Medical College of Wisconsin, USA
•    Lancaster General Hospital, USA
•    University of Kansas Hospital, USA
•    Hospital Municipal Mendez, Argentina

Asian Region
•    Royal Prince Alfred Hospital, Australia
•    Royal Melbourne Hospital, Australia
•    Waikato Hospital, New Zealand
•    Faculty of Medicine Siriraj Hospital, Thailand
•    Prince Court Medical Centre, Malaysia
•    Fortis C-DOC Hospital, India
•    S. L Raheja Hospital, India
•    Apollo Hospitals, India
•    Indraprastha Apollo Hospital, India
•    Manipal Hospital, India
•    Tongji Hospital, China
•    Peking University People's Hospital, China
•    Peking University First Hospital, China
•    Bumrungrad International Hospital, Thailand
•    Bangkok Hospital Medical Center, Thailand
•    Gleneagles Hospital, Singapore

Middle East Region
•    King Faisal Specialist Hospital & Research Centre, Saudi Arabia
•    Riyadh Military Hospital, Saudi Arabia
•    Kbb Istanbul, Turkey
•    Ankara Saglik Müdürlügü, Turkey
•    Medicana Hospital Group, Turkey
•    American Hospital, UAE
•    Bezmi Alem Valide Sultan Vakif Gureba E A Hastanesi, Turkey
•    Hille Yaffe Medical Center, Israel
•    Erfan Hospital, Saudi Arabia
•    Ankara Numone Hospital, Turkey
•    Zulekha Hospital, UAE
•    Denizli Devlet Hastanesi, Turkey
•    King Fahad Medical Ci, Saudi Arabia

Europe Region
•    Swiss Prevention Clinic, Switzerland
•    Klinik Pyramide Am See, Switzerland
•    Health Centre, Switzerland
•    Clinique Générale-Beaulieu, Switzerland
•    Klinik Im Park, Switzerland
•    Klinik Hirslanden, Switzerland
•    Klinik Beau-Site, Switzerland
•    Hirslanden Clinique La Colline, Switzerland
•    Salem-Spital, Switzerland
•    Hirslanden Klinik, Switzerland
•    W. Goethe university hospital, Germany

Global Diabetes-Endocrinology Companies
•    Abbott Diabetes Care, USA
•    Accu-Chek, USA
•    Arkray USA, USA
•    Bayer, USA
•    LifeScan, USA
•    Animas, USA
•    Asante Solutions, USA
•    Abbot Laboratories, USA
•    Amylin Pharmaceuticals, USA
•    Aventis Pharmaceuticals, USA
•    Becton-Dickinson, USA
•    Bristol-Myers Squibb, USA
•    Novo Nordisk, USA
•    Pfizer, USA
•    SmithKline Beecham, USA
•    Takeda Pharmaceuticals, USA
•    Valeant, USA
•    Euradia, UK
•    MedTech Europe, Belgium
•    Cellnovo, France
•    Novo-Nordisk, Denmark
•    Acino, France
•    Thio Matrix -Austria
•    Biocrates, Austria

Meetings International is announcing the Young Scientist Awards through the 5th International Conference on Diabetes & Endocrinology which is scheduled for November 13-14, 2024 in Dubai, UAE. This Diabetes Conference focuses on “Diabetes and recent advances in it’s management”.

Diabetes 2024 and upcoming conferences will recognise participants who have significantly added value to the scientific community of Endocrinologists and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.
Diabetes 2024 focuses mainly the endocrinology, diabetes and metabolic syndrome. Diabetes 2024 conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.
Eligibility:
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. candidates. Persons from Scientific Industry can also participate.
Benefits: 
The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

• Acknowledgement as YRF Awardee
• Promotion on the conference website, Young Researcher Awards and certificates
• Link on the conference website
• Recognition on Meetings Int. Award Page
• Chances to coordinate with partners around the world
• Research work can be published in the relevant journal without any publication fee

Criteria:

• All presented abstracts will automatically be considered for the Award.
• All the presentation will be evaluated in the conference venue
• All the awards will be selected by the judges of the award category
• The winners of the Young Scientist Award will receive award certificate.
• The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

• All submissions must be in English.
• The topic must fit into scientific sessions of the conference
• Each individual participant is allowed to submit maximum 2 papers
• Abstract must be submitted online as per the given abstract template
• Abstracts must be written in Times New Roman and font size will be 12
• Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author's permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:
The official announcement of the recipients will occur after the completion of the Diabetes Conference.

5th International Conference on Diabetes & Endocrinology assists to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, includes banners, sponsored emails, article alerts or newsletters, which provides the clients with the very best customized marketing opportunities in science and medicine.
We are one of the renowned events organizing platform with most of eminent speakers and business audience form all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company.
If you are looking for a global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3 million hits a month on our website, we have engaged audience including students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the domains.
If you sell research materials, products, diabetes therapy related medicine, different diabetes techniques, instruments, or other related services, here is your opportunity to advertise in the website that can connect you to leading experts and science specialists across the Globe.
Advertisement banner must be provided in high resolution jpg or jpeg format by the advertising company and must not have copyright infringement. We can also support your events and conferences by providing you with high quality reprints of published articles that can add value to your event.
For any queries regarding advertising opportunities, please contact: contact@meetingsint.com